Market Access Insights

Access timely, relevant information

IQVIA’s Market Access Insights provides you with comprehensive, relevant, and actionable content so that you can make informed market access decisions.

Market Access Insights

Gain access to simple, powerful searches with up-to-date, easy-to-navigate results and the option of data analysis and visualizations – all in one place. Leverage Market Access Insights to get latest information on HTA reviews, reimbursement decisions, regulatory updates, clinical trials, and pricing. Access to data is flexible and customizable, so you can choose between export the data yourself or work with our experienced team for reports, assessments, trackers and more.

Benefits for users

Iqvia Human data science

Benefits for your business

Supporting you through the product lifecycle

Obtaining and keeping market access for your drug is not a one-time activity, but decisions need to be made throughout the entire product lifecycle, from early-stage development through lifecycle management. Click on the stages to learn how Market Access Insights can provide value throughout a product’s lifecycle.

Phase II

  • Understand the market access landscape to mitigate potential payer challenges and identify opportunities
  • Create integrated evidence strategies with market access requirements in mind to increase the probability of market access success
  • Prepare for early scientific advice with HTA bodies
  • Support asset due diligence early on

Phase III

  • Design your trial so it provides robust evidence and demonstrates improvement in outcomes relevant to payers
  • Build strategies to incorporate patient-reported outcomes and real world evidence in your trial protocol that are relevant to HTA bodies
  • Predict HTA outcomes based on main decision drivers and develop mitigation plans for payer challenges

Regulatory approval

  • Coordinate regulatory and market access strategies
  • Align regulatory label and market access implications of patient populations

HTA, pricing and reimbursement

  • Build indication-specific payer strategies
  • Prepare for dossier submissions and mitigation of challenges
  • Prepare for pricing & reimbursement discussions
  • Assess the impact of major policy decisions, such as the European Joint Clinical Assessments
pharmacists hands taking medicines from shelf

Launch and post-launch

  • Plan and prepare for price and reimbursement discussions
  • Strategize for and understand pricing implications of product extensions
  • Evaluate the impact of further RWE collection
  • Examine and mitigate the risk of the evolving competitive landscape and impact of new entrants

Related solutions

Contact Us